What is CDTX stock price today?

Visit our real-time dashboard for the current CDTX stock price and live market data.

Is CDTX stock going up or down today?

CDTX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CDTX stock now?

The decision to buy CDTX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CDTX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CDTX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CDTX stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CDTX is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CDTX's P/E ratio?

P/E ratio data for CDTX will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CDTX's market cap?

CDTX (Cidara Therapeutics Inc) has a market capitalization of $6.96 billion, making it a small-cap stock.

What is CDTX's price to book ratio?

Price-to-book ratio for CDTX is available on our dashboard along with other valuation metrics.

Does CDTX pay dividends?

CDTX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CDTX's dividend yield?

CDTX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CDTX stock a good long-term investment?

CDTX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CDTX's revenue growth rate?

Revenue growth data for CDTX is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CDTX are available on our dashboard with complete income statement analysis.

What are the risks of investing in CDTX?

Key risks for CDTX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CDTX compare to its competitors?

Compare CDTX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CDTX's performance and positioning.

What is CDTX's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CDTX with bull, base, and bear case scenarios.

What do analysts say about CDTX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CDTX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CDTX's next earnings report?

CDTX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CDTX - Cidara Therapeutics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Cidara Therapeutics Inc

Cidara Therapeutics Inc (CDTX) common stock

Price Chart

Loading chart...

CDTX Key Statistics

Market Cap

$6.96B

How CDTX Compares to Peers

CDTX is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 4

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
CDTX(This stock)	$6.96B	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 8, 2026 at 1:26 PM EDT

Ready to invest in CDTX?

Commission-free trading available. Affiliate links.

CDTX Lician Score

10% confidence

4.0/10

Neutral

CDTX has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

1.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates CDTXacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

CDTX Financial Snowflake

5-axis analysis across key investment dimensions

4.2/10

Neutral

5.0

Value

Valuation vs. sector peers

1.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for CDTX

Dashboard

Enter a ticker to analyze